Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Oral contraceptive potencies and side effects.

G S Berger, P P Talwar

    Obstetrics and Gynecology
    |May 1, 1978
    PubMed
    Summary

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Successful pregnancy in a 42-year-old woman with imminent ovarian failure following ovulation induction with ethinyl estradiol without gonadotropins and in vitro fertilization.

    Clinical and experimental obstetrics & gynecology·2002
    Same author

    An analytical framework for the study of proximate determinants of maternal mortality.

    Indian journal of maternal and child health : official publication of Indian Maternal and Child Health Association·1997
    Same author

    Outpatient pelvic laparotomy.

    The Journal of reproductive medicine·1994
    Same author

    Population profile of India: past, present and future.

    Health for the millions·1994
    Same author

    Management of high risk mothers and maternal mortality in Indian population.

    Indian journal of maternal and child health : official publication of Indian Maternal and Child Health Association·1993
    Same author

    Health for all and population stabilization in India.

    Journal Of Rural Development·1991

    This study tested a model for ranking oral contraceptive hormonal potencies. The model inaccurately predicted estrogenic and progestogenic side effect rankings for some contraceptives.

    Area of Science:

    • Pharmacology
    • Endocrinology
    • Drug Development

    Background:

    • Oral contraceptives (OCs) are widely used for birth control.
    • Hormonal potency and associated side effects are critical factors in OC selection.
    • Accurate models predicting relative hormonal potencies are needed.

    Purpose of the Study:

    • To evaluate a model designed to rank oral contraceptives by relative hormonal potencies.
    • To assess the model's accuracy in predicting side effects related to estrogen and progestin excess.

    Main Methods:

    • Empirical data on oral contraceptives were collected.
    • A predictive model for hormonal potency ranking was utilized.
    • Observed side effect incidence was compared against model predictions.
    Keywords:
    Acceptor CharacteristicsAcceptorsContraceptionContraceptive Agents, Estrogen--side effectsContraceptive Agents, Female--side effectsContraceptive Agents, Progestin--side effectsContraceptive Agents--side effectsContraceptive Methods--side effectsDouble-blind StudiesEthinyl Estradiol--side effectsFamily PlanningFamily Planning ProgramsMestranol--side effectsNorethindrone Acetate--side effectsNorethindrone--side effectsNorethynodrel--side effectsOral Contraceptives, CombinedOral Contraceptives--side effectsProspective StudiesResearch MethodologyStudies

    Related Experiment Videos

    Main Results:

    • The model inaccurately predicted the ranking order of symptoms associated with excess estrogen.
    • While Ovral was correctly identified as having the highest progestogenic potency, the ranking of other OCs was reversed.
    • Discrepancies were observed between predicted and actual side effect profiles.

    Conclusions:

    • The current model requires refinement for accurate prediction of OC hormonal potencies and associated side effects.
    • Clinical implications include potential for improved OC selection and management of adverse effects.
    • Further research is needed to enhance predictive models in pharmacotherapy.